Ching-Sheng Hsu (C-S Hsu)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 5

Top Topics

Hepatitis C Virus

Peritoneal Dialysis

Risk Assessment

Gastroesophageal Reflux Disease

Top Venues

Hepatology international

Journal of gastroenterology and hepatology

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tzu-Rong Peng, Yi-Fang Weng, Ta-Wei Wu, Chao-Chuan Wu, Yi-Chun Chou, Ching-Sheng Hsu
Efficacy and Safety of Sorafenib or Lenvatinib for Advanced Hepatocellular Carcinoma after Failure of First-Line Atezolizumab Plus Bevacizumab: A Systematic Review and Meta-Analysis. Cancers 16 (16) (2024)
Tzu-Rong Peng, Yi-Fang Weng, Ta-Wei Wu, Chao-Chuan Wu, Yi-Chun Chou, Ching-Sheng Hsu
Efficacy and Safety of Sorafenib or Lenvatinib for Advanced Hepatocellular Carcinoma after Failure of First-Line Atezolizumab Plus Bevacizumab: A Systematic Review and Meta-Analysis. Cancers 16 (16) (2024)
Ming-Wun Wong, Ming-Jong Bair, Wei-Chuan Chang, Ching-Sheng Hsu, Jui-Sheng Hung, Tso-Tsai Liu, Chih-Hsun Yi, Wei-Yi Lei, Michael F Vaezi, C Prakash Gyawali, Chien-Lin Chen
Clinical and psychological characteristics in gastroesophageal reflux disease patients overlapping with laryngopharyngeal reflux symptoms. Journal of gastroenterology and hepatology 34 (10) (2019)
Ching-Sheng Hsu, Hui-Chu Lang, Kuang-Yung Huang, You-Chen Chao, Chien-Lin Chen
Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in Taiwan. Hepatology international 12 (6) (2018)
Ching-Sheng Hsu, P-C Wang, C-H Li, H H Lin
Letter: HBV/HCV coinfection in the era of direct-acting antivirals. Alimentary pharmacology & therapeutics 46 (2) (2017)